#clinical trials

AIM ImmunoTech Inc. (NYSE American:AIM) today announced the filing of three provisional patent applications related to ...

- Invicro LLC, a Konica Minolta company, today announces, Dr. Matthew Silva has been appointed as the new Chief ...

- Terns Pharmaceuticals, Inc. today announced an exclusive licensing and collaboration agreement with GENFIT (GNFT), a ...

- Teijin Limited announced today that it has reached an agreement with The Healthy Grain Pty. Limited, an Australian ...

Novotech, the award-winning Asia-Pacific CRO with 23 years of experience in the region, has further strengthened its ...

- PanTheryx, a biotechnology company committed to realizing the potential of novel interventions to address a wide ...

- Terns Pharmaceuticals Inc., a global biopharmaceutical company focused on discovering and developing molecularly ...

- AMPLEXOR: MEDIA ADVISORY:      Now in its fifth year, Pharmacon Asia 2018 is one of the ...

- Celgene Corporation (NASDAQ: CELG) and Acceleron Pharma Inc. (NASDAQ: XLRN) today announced results from a phase III, ...

- 2017: Octapharma is pleased to announce the completion of a charitable donation of 30.5 million international units ...

- 22nd Century Group, Inc. (NYSE American: XXII), a plant biotechnology company that is focused on ...

A future where faecal transplants in China will cure conditions like autism, IBD, arthritis, Parkinson's disease and ...

- Philip Morris International Inc. (PMI) (NYSE/Euronext Paris: PM) today announces the positive results from an ...

Frost & Sullivan today released its latest white paper, 'Asia: Preferred Destination for Clinical Trials', with ...

- LFB S.A., announced that its Biologic License Application (BLA), requesting marketing approval of ...